Rebecca Bahn

Summary

Affiliation: Mayo Clinic
Country: USA

Publications

  1. ncbi A small molecule antagonist inhibits thyrotropin receptor antibody-induced orbital fibroblast functions involved in the pathogenesis of graves ophthalmopathy
    Adina F Turcu
    MD, Division of Endocrinology, Diabetes, Metabolism and Nutrition, Mayo Clinic, 200 First Street Southwest, Rochester, Minnesota 55902
    J Clin Endocrinol Metab 98:2153-9. 2013
  2. ncbi A stimulatory thyrotropin receptor antibody enhances hyaluronic acid synthesis in graves' orbital fibroblasts: inhibition by an IGF-I receptor blocking antibody
    Seema Kumar
    Division of Pediatric Endocrinology and Metabolism, Mayo Clinic, 200 First Street SW, Rochester, Minnesota 55902, USA
    J Clin Endocrinol Metab 97:1681-7. 2012
  3. ncbi Autoimmunity and Graves' disease
    R S Bahn
    Division of Endocrinology, Diabetes, Metabolism and Nutrition, Mayo Clinic School of Medicine, Mayo Clinic, Rochester, Minnesota, USA
    Clin Pharmacol Ther 91:577-9. 2012
  4. ncbi Hyperthyroidism and other causes of thyrotoxicosis: management guidelines of the American Thyroid Association and American Association of Clinical Endocrinologists
    Rebecca S Bahn Chair
    Division of Endocrinology, Metabolism, and Nutrition, Mayo Clinic, Rochester, Minnesota 55905, USA
    Thyroid 21:593-646. 2011
  5. ncbi Clinical review 157: Pathophysiology of Graves' ophthalmopathy: the cycle of disease
    Rebecca S Bahn
    Division of Endocrinology, Metabolism, and Nutrition, Mayo Clinic, Rochester, Minnesota 55905, USA
    J Clin Endocrinol Metab 88:1939-46. 2003
  6. ncbi Thyrotropin receptor expression in orbital adipose/connective tissues from patients with thyroid-associated ophthalmopathy
    Rebecca S Bahn
    Division of Endocrinology, Metabolism and Nutrition, Mayo Clinic Foundation, Rochester, Minnesota 55905, USA
    Thyroid 12:193-5. 2002
  7. ncbi TSH receptor expression in orbital tissue and its role in the pathogenesis of Graves' ophthalmopathy
    R S Bahn
    Division of Endocrinology, Metabolism and Nutrition, Mayo Clinic, Rochester, MN 55905, USA
    J Endocrinol Invest 27:216-20. 2004
  8. ncbi Thyrotropin receptor expression in Graves' orbital adipose/connective tissues: potential autoantigen in Graves' ophthalmopathy
    R S Bahn
    Division of Endocrinology, Mayo Clinic Foundation, Rochester, Minnesota 55905, USA
    J Clin Endocrinol Metab 83:998-1002. 1998
  9. ncbi Thyrotropin receptor expression in cultured Graves' orbital preadipocyte fibroblasts is stimulated by thyrotropin
    R S Bahn
    Division of Endocrinology, Mayo Clinic Foundation, Rochester, Minnesota 55905, USA
    Thyroid 8:193-6. 1998
  10. ncbi Understanding the immunology of Graves' ophthalmopathy. Is it an autoimmune disease?
    R S Bahn
    Mayo Medical School, Rochester, Minnesota, USA
    Endocrinol Metab Clin North Am 29:287-96, vi. 2000

Collaborators

Detail Information

Publications33

  1. ncbi A small molecule antagonist inhibits thyrotropin receptor antibody-induced orbital fibroblast functions involved in the pathogenesis of graves ophthalmopathy
    Adina F Turcu
    MD, Division of Endocrinology, Diabetes, Metabolism and Nutrition, Mayo Clinic, 200 First Street Southwest, Rochester, Minnesota 55902
    J Clin Endocrinol Metab 98:2153-9. 2013
    ....
  2. ncbi A stimulatory thyrotropin receptor antibody enhances hyaluronic acid synthesis in graves' orbital fibroblasts: inhibition by an IGF-I receptor blocking antibody
    Seema Kumar
    Division of Pediatric Endocrinology and Metabolism, Mayo Clinic, 200 First Street SW, Rochester, Minnesota 55902, USA
    J Clin Endocrinol Metab 97:1681-7. 2012
    ..The expansion of orbital tissues involves accumulation of hyaluronic acid (HA) within the orbit...
  3. ncbi Autoimmunity and Graves' disease
    R S Bahn
    Division of Endocrinology, Diabetes, Metabolism and Nutrition, Mayo Clinic School of Medicine, Mayo Clinic, Rochester, Minnesota, USA
    Clin Pharmacol Ther 91:577-9. 2012
    ..In addition, rituximab (RTX) is the first targeted biological therapy to be studied as treatment for these conditions...
  4. ncbi Hyperthyroidism and other causes of thyrotoxicosis: management guidelines of the American Thyroid Association and American Association of Clinical Endocrinologists
    Rebecca S Bahn Chair
    Division of Endocrinology, Metabolism, and Nutrition, Mayo Clinic, Rochester, Minnesota 55905, USA
    Thyroid 21:593-646. 2011
    ..This article describes evidence-based clinical guidelines for the management of thyrotoxicosis that would be useful to generalist and subspeciality physicians and others providing care for patients with this condition...
  5. ncbi Clinical review 157: Pathophysiology of Graves' ophthalmopathy: the cycle of disease
    Rebecca S Bahn
    Division of Endocrinology, Metabolism, and Nutrition, Mayo Clinic, Rochester, Minnesota 55905, USA
    J Clin Endocrinol Metab 88:1939-46. 2003
  6. ncbi Thyrotropin receptor expression in orbital adipose/connective tissues from patients with thyroid-associated ophthalmopathy
    Rebecca S Bahn
    Division of Endocrinology, Metabolism and Nutrition, Mayo Clinic Foundation, Rochester, Minnesota 55905, USA
    Thyroid 12:193-5. 2002
    ..Some of these may impact the expression of TSHr, the putative orbital autoantigen in this condition...
  7. ncbi TSH receptor expression in orbital tissue and its role in the pathogenesis of Graves' ophthalmopathy
    R S Bahn
    Division of Endocrinology, Metabolism and Nutrition, Mayo Clinic, Rochester, MN 55905, USA
    J Endocrinol Invest 27:216-20. 2004
    ..Alternately, locally enhanced expression of this protein at the sites of clinical disease may not be directly involved in pathogenesis, but could be secondary to the ongoing process, and nonetheless important in disease progression...
  8. ncbi Thyrotropin receptor expression in Graves' orbital adipose/connective tissues: potential autoantigen in Graves' ophthalmopathy
    R S Bahn
    Division of Endocrinology, Mayo Clinic Foundation, Rochester, Minnesota 55905, USA
    J Clin Endocrinol Metab 83:998-1002. 1998
    ..These results suggest that both the expression of this receptor and the accumulation of adipose tissue in the orbit in GO may be induced in vivo by a humoral factor(s) not present in the cell culture environment...
  9. ncbi Thyrotropin receptor expression in cultured Graves' orbital preadipocyte fibroblasts is stimulated by thyrotropin
    R S Bahn
    Division of Endocrinology, Mayo Clinic Foundation, Rochester, Minnesota 55905, USA
    Thyroid 8:193-6. 1998
    ..These studies suggest that the expression of this receptor in the orbit in vivo may be stimulated by TSH or other TSHr ligands, and that this stimulation may be important in the development of GO...
  10. ncbi Understanding the immunology of Graves' ophthalmopathy. Is it an autoimmune disease?
    R S Bahn
    Mayo Medical School, Rochester, Minnesota, USA
    Endocrinol Metab Clin North Am 29:287-96, vi. 2000
    ..Future studies using animal models and in vitro systems will allow definitive identification of the immune cell types, autoantigens, and autoantibodies involved in the pathogenesis of Graves' ophthalmopathy...
  11. ncbi Differentiation of human orbital preadipocyte fibroblasts induces expression of functional thyrotropin receptor
    R W Valyasevi
    Division of Endocrinology, Mayo Clinic Foundation, Rochester, Minnesota 55905, USA
    J Clin Endocrinol Metab 84:2557-62. 1999
    ..Furthermore, our studies support the concept that TSHr may be an important target antigen in this condition. Factors that stimulate adipocyte differentiation and TSHr expression in the orbit in GO have yet to be defined...
  12. ncbi Induction of leptin expression in orbital preadipocyte fibroblasts
    D Z Erickson
    Division of Endocrinology, Metabolism and Nutrition, Mayo Clinic/Foundation, Rochester, Minnesota 55905, USA
    Thyroid 11:221-6. 2001
    ..This process would be expected to result in expansion of the orbital adipose tissues and increased TSHR expression within the orbit...
  13. ncbi Effect of tumor necrosis factor-alpha, interferon-gamma, and transforming growth factor-beta on adipogenesis and expression of thyrotropin receptor in human orbital preadipocyte fibroblasts
    R W Valyasevi
    Division of Endocrinology, Metabolism and Nutrition, Mayo Clinic/Foundation, Rochester, Minnesota 55905, USA
    J Clin Endocrinol Metab 86:903-8. 2001
    ..In addition, the former two cytokines may play a role in determining the extent to which the volume of the orbital adipose tissue increases in this condition...
  14. ncbi Interleukin-6 stimulates thyrotropin receptor expression in human orbital preadipocyte fibroblasts from patients with Graves' ophthalmopathy
    S C Jyonouchi
    Division of Endocrinology, Metabolism and Nutrition, Mayo Clinic Foundation, Rochester, Minnesota 55905, USA
    Thyroid 11:929-34. 2001
    ..These findings suggest that IL-6 may play a role in the pathogenesis of GO by increasing expression of the putative autoantigen within the adipose/connective tissues of the orbit...
  15. ncbi A prospective, randomized, double-blind, placebo-controlled study of orbital radiotherapy for Graves' ophthalmopathy
    C A Gorman
    Division of Endocrinology, Mayo Clinic, Rochester, Minnesota 55905, USA
    Ophthalmology 108:1523-34. 2001
    ..Although widely used for more than 85 years, the efficacy of radiotherapy for Graves' ophthalmopathy (GO) has not been established convincingly...
  16. ncbi Depressive relapse during lithium treatment associated with increased serum thyroid-stimulating hormone: results from two placebo-controlled bipolar I maintenance studies
    M A Frye
    Department of Psychiatry and Psychology, Mayo Clinic, Rochester, MN 55905, USA
    Acta Psychiatr Scand 120:10-3. 2009
    ..To assess the relationship between depressive relapse and change in thyroid function in an exploratory post hoc analysis from a controlled maintenance evaluation of bipolar I disorder...
  17. ncbi A genomic point mutation in the extracellular domain of the thyrotropin receptor in patients with Graves' ophthalmopathy
    R S Bahn
    Department of Internal Medicine, Mayo Clinic Foundation, Rochester, Minnesota 55905
    J Clin Endocrinol Metab 78:256-60. 1994
    ..We suggest that the TSH receptor may be an important fibroblast autoantigen in GO and PTD, and that this mutant form of the receptor may have unique immunogenic properties...
  18. ncbi Immunopathogenesis of Graves' ophthalmopathy: the role of the TSH receptor
    Seethalakshmi Iyer
    Division of Endocrinology, Metabolism and Nutrition, Mayo Clinic, 200 First Street SW, Rochester, MN 55905, USA
    Best Pract Res Clin Endocrinol Metab 26:281-9. 2012
    ..Future therapies for this condition may involve inhibition of thyrotropin receptor signaling in orbital fibroblasts...
  19. ncbi Normal function in vivo of a homozygotic polymorphism in the human thyrotropin receptor
    R M Cuddihy
    Department of Internal Medicine, Mayo Clinic and Foundation, Rochester, Minnesota 55905, USA
    Thyroid 5:255-7. 1995
    ....
  20. ncbi Relative overexpression of macrophage-derived cytokines in orbital adipose tissue from patients with graves' ophthalmopathy
    Seema Kumar
    Division of Pediatric Endocrinology, Clinic, Rochester, Minnesota 55905, USA
    J Clin Endocrinol Metab 88:4246-50. 2003
    ..In addition, the overexpression of IFN-gamma, without evidence of IL-4 or IL-5 expression, supports the concept that cell-mediated, rather than humoral, immunity plays the predominant role in pathogenesis of this disorder...
  21. ncbi Stimulation of adipogenesis, peroxisome proliferator-activated receptor-gamma (PPARgamma), and thyrotropin receptor by PPARgamma agonist in human orbital preadipocyte fibroblasts
    Rosanee W Valyasevi
    Division of Endocrinology, Metabolism, and Nutrition, Mayo Clinic/Foundation, Rochester, Minnesota 55905, USA
    J Clin Endocrinol Metab 87:2352-8. 2002
    ..It is possible that endogenous PPARgamma ligands play a role in stimulating orbital adipogenesis in GO, and that future treatments may be aimed at antagonism of various components of the PPARgamma signaling system...
  22. ncbi Retinal microvascular abnormalities in patients treated with external radiation for graves ophthalmopathy
    Dennis M Robertson
    Department of Ophthalmology, Division of Endocrinology, Mayo Clinic, Rochester, MN 55905, USA
    Arch Ophthalmol 121:652-7. 2003
    ..Radiation was directed to the orbits of 42 affected patients using 0.2 rad (20 Gy) delivered in 10 doses of 0.02 rad (2 Gy). Patients were periodically examined during a 3-year interval...
  23. ncbi How perceived physician leadership behavior affects physician satisfaction
    Ronald Menaker
    Administrative Services, Mayo Clinic, 200 First St SW, Rochester, MN 55905, USA
    Mayo Clin Proc 83:983-8. 2008
    ....
  24. ncbi Pathogenesis of Graves' ophthalmopathy: the role of autoantibodies
    Teck Kim Khoo
    Division of Endocrinology and Metabolism, Department of Internal Medicine, Mayo Clinic, Rochester, Minnesota, USA
    Thyroid 17:1013-8. 2007
    ..Although originally thought to represent another causative agent, antibodies to extraocular muscles are now generally thought to be secondary to extraocular muscle inflammation and damage...
  25. ncbi The impact of overt and subclinical hyperthyroidism on skeletal muscle
    Michael D Brennan
    Division of Endocrinology, Diabetes, Nutrition and Metabolism, Mayo Clinic, Rochester, Minnesota 55905, USA
    Thyroid 16:375-80. 2006
    ..This may have clinical relevance as SCH patients are often elderly and may therefore have concurrent sarcopenia of aging and would represent a previously unrecognized complication of SCH...
  26. ncbi Thyroid transcription factor-1 in orbital adipose tissues: potential role in orbital thyrotropin receptor expression
    Kalyan K Bhattacharyya
    Division of Endocrinology, Metabolism and Nutrition, Mayo Clinic, Rochester, Minnesota 55905, USA
    Thyroid 15:422-6. 2005
    ..The presence of mRNA encoding TTF-1 in orbital tissues and cultures suggest that this transcription factor may play an important role in extrathyroidal, as it does in thyroidal, TSHR expression...
  27. ncbi Gene expression profiling of orbital adipose tissue from patients with Graves' ophthalmopathy: a potential role for secreted frizzled-related protein-1 in orbital adipogenesis
    Seema Kumar
    Division of Pediatric Endocrinology, Mayo Clinic, 200 First Street SW, Rochester, Minnesota 55905, USA
    J Clin Endocrinol Metab 90:4730-5. 2005
    ..The signs and symptoms of Graves' ophthalmopathy (GO) result from inflammation and increased volume of the orbital adipose tissues and extraocular muscles...
  28. ncbi Current perspective on the pathogenesis of Graves' disease and ophthalmopathy
    Bellur S Prabhakar
    Department of Microbiology and Immunology, College of Medicine, University of Illinois at Chicago, Chicago, Illinois 60612 7344, USA
    Endocr Rev 24:802-35. 2003
    ..Collectively, recent studies have led to a better understanding of the pathogenesis of GD and GO and have opened up potential new avenues for developing novel treatments for GD and GO...
  29. ncbi Evidence for enhanced adipogenesis in the orbits of patients with Graves' ophthalmopathy
    Seema Kumar
    Division of Pediatric Endocrinology, Mayo Clinic, Rochester, Minnesota 55905, USA
    J Clin Endocrinol Metab 89:930-5. 2004
    ....
  30. ncbi Clinical significance of diffusely increased 18F-FDG uptake in the thyroid gland
    Dimitrios Karantanis
    Division of Nuclear Medicine, Department of Radiology, Mayo Clinic, Rochester, Minnesota 55905, USA
    J Nucl Med 48:896-901. 2007
    ..Our purpose was to determine the clinical significance of diffusely increased (18)F-FDG uptake in the thyroid gland as an incidental finding on PET/CT...
  31. ncbi Optic neuropathy of Graves disease: results of transantral orbital decompression and long-term follow-up in 215 patients
    Cacia V Soares-Welch
    Division of Endocrinology, Diabetes, Metabolism, Nutrition and Internal Medicine, Mayo Clinic, Rochester, Minnesota 55905, USA
    Am J Ophthalmol 136:433-41. 2003
    ..CONCLUSIONS: Transantral orbital decompression appeared to be effective in treating optic neuropathy of Graves disease. Patient satisfaction was high at 10-year and 20-year follow-up...
  32. ncbi The aftermath of orbital radiotherapy for graves' ophthalmopathy
    Colum A Gorman
    Department of Medicine, Mayo Clinic, Rochester, Minnesota. Department of Ophthalmology, Mayo Clinic, Rochester, Minnesota 55905, USA
    Ophthalmology 109:2100-7. 2002
    ..In either case, the changes are of little clinical significance. Because it is neither effective nor innocuous, radiotherapy does not seem to be indicated for treatment of mild to moderate ophthalmopathy...
  33. ncbi Effects of reducing the upper limit of normal TSH values
    Vahab Fatourechi
    JAMA 290:3195-6. 2003

Research Grants19

  1. Thyrotropin Receptor Auto Antibodies in Graves' Ophthalmopathy
    Rebecca S Bahn; Fiscal Year: 2010
    ..Our studies will yield information concerning mechanisms involved in disease development, and will determine the effectiveness of a novel approach to therapy. ..
  2. Thyrotropin Receptor Auto Antibodies in Graves' Ophthalmopathy
    Rebecca Bahn; Fiscal Year: 2009
    ..Our studies will yield information concerning mechanisms involved in disease development, and will determine the effectiveness of a novel approach to therapy. ..
  3. Thyrotropin Receptor Auto Antibodies in Graves' Ophthalmopathy
    Rebecca Bahn; Fiscal Year: 2007
    ..Our studies will yield information concerning mechanisms involved in disease development, and will determine the effectiveness of a novel approach to therapy. ..
  4. EYE IN GRAVES DISEASE--ROLE OF ORBITAL FIBROBLASTS
    Rebecca Bahn; Fiscal Year: 2004
    ..The main goal of the research program is to increase understanding of the orbital immune response in GO in order that novel and more specific therapeutic and preventive strategies for this condition might be developed. ..
  5. EYE IN GRAVES' DISEASE--ROLE OF ORBITAL FIBROBLASTS
    Rebecca Bahn; Fiscal Year: 1993
    ..The investigators believe these studies will enhance their understanding of disease pathogenesis which will translate into improve management strategies and eventually better clinical outcomes...
  6. Thyrotropin Receptor Auto Antibodies in Graves' Ophthalmopathy
    Rebecca S Bahn; Fiscal Year: 2010
    ..Our studies will yield information concerning mechanisms involved in disease development, and will determine the effectiveness of a novel approach to therapy. ..